Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Pneumonia
ADR ID BADD_A03470
ADR Hierarchy
22      Respiratory, thoracic and mediastinal disorders
22.07      Respiratory tract infections
22.07.01      Lower respiratory tract infections NEC
22.07.01.003      Pneumonia
11      Infections and infestations
11.01      Infections - pathogen unspecified
11.01.09      Lower respiratory tract and lung infections
11.01.09.003      Pneumonia
Description Inflammation of the lung parenchyma that is associated with BRONCHITIS, usually involving lobular areas from TERMINAL BRONCHIOLES to the PULMONARY ALVEOLI. The affected areas become filled with exudate that forms consolidated patches. [MeSH]
MedDRA Code 10035664
MeSH ID D001996; D011014; D000077299; D011001; D053717
ADR Severity Grade (FAERS) Not Available
ADR Severity Grade (CTCAE) Not Available
Synonym
Bronchial pneumonia | Bronchopneumonia | Bronchopneumonia NOS | Bronchopneumonia, organism unspecified | Community acquired pneumonia | Lobar pneumonia | Lobar pneumonia NOS | Multilobar pneumonia | Pneumonia | Pneumonia congestive | Pneumonia due to other specified organism | Pneumonia in infectious diseases classified elsewhere | Pneumonia in other infectious diseases classified elsewhere | Pneumonia lobar | Pneumonia NOS | Pneumonia, organism unspecified | Rheumatic pneumonia | Pneumonia aggravated | Lung infection NOS | Superinfection lung | Pulmonary suppuration | Bronchopulmonary infection | Nosocomial pneumonia | Bilateral pneumonia | Pneumonia following pulmonary infarction | Pneumonia hypostatic | Pleuropneumonia | Lung infection | Obstructive pneumonia | Ventilator associated pneumonia | Acute bronchopneumonia | Acute pneumonia | Pneumonia recurrent | Infectious pneumonitis | Hospital acquired pneumonia | Healthcare associated pneumonia | Bilateral bronchopneumonia | Post-stenotic pneumonia | Right middle lobe pneumonia | Chronic pneumonia | Polysegmental pneumonia | Bronchopneumonias | Bronchial Pneumonia | Bronchial Pneumonias | Pneumonia, Bronchial | Pneumonias, Bronchial
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D02236Tofacitinib--
BADD_D02237Tofacitinib citrate--
BADD_D02241Tolcapone--
BADD_D02247Topiramate--
BADD_D02248Topotecan--
BADD_D02249Topotecan hydrochloride--
BADD_D02252Tositumomab--
BADD_D02254Tramadol--
BADD_D02268Treprostinil--
BADD_D02270Tretinoin--
BADD_D02315Umeclidinium bromide--
BADD_D02321Ursodiol--
BADD_D02322Ustekinumab--
BADD_D02325Valdecoxib--
BADD_D02326Valganciclovir--
BADD_D02328Valproate sodium--
BADD_D02329Valproic acid--
BADD_D02330Valrubicin--
BADD_D02334Vandetanib--
BADD_D02345Venetoclax--
BADD_D02346Venlafaxine--
BADD_D02352Verteporfin--
BADD_D02355Vigabatrin--
BADD_D02360Vincristine--
BADD_D02361Vincristine sulfate--
BADD_D02362Vinflunine--
BADD_D02363Vinorelbine--
BADD_D02364Vinorelbine tartrate--
BADD_D02367Voltaren--
BADD_D02369Voriconazole--
The 15th Page    First    Pre   15 16    Next   Last    Total 16 Pages
ADReCS-Target
ADR Term Drug Name Target